Citius Oncology (CTOR)

• Market cap: $86.5M
• 1 day: -2.86%
• 5 days: -12.07%
• 1 month: -16.39%
• 3 months: -45.16%
• 6 months: -26.62%
• Year to date: -14.29%
• 1 year: -7.27%
• 5 years: -89.89%
• 10 years: -89.89%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.